3

PRIMARY DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: May 30, 2013
Period of Report: May 22, 2013
Accession Number: 0001513160-13-000033

View Document ↗ View on SEC.gov ↗